Hidden hazards of Bosentan therapy in pulmonary hypertension

Ann Card Anaesth. 2008 Jul-Dec;11(2):138; author reply 138-9. doi: 10.4103/0971-9784.41593.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Abnormalities, Drug-Induced
  • Antihypertensive Agents / adverse effects*
  • Bosentan
  • Chemical and Drug Induced Liver Injury
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Randomized Controlled Trials as Topic
  • Sulfonamides / adverse effects*

Substances

  • Antihypertensive Agents
  • Sulfonamides
  • Bosentan